Stockscreener 앱 받기
5.19
2.37%
0.12
시간 외 거래:
5.16
-0.03
-0.58%
전일 마감가:
$5.07
열려 있는:
$5.09
하루 거래량:
66,847
Relative Volume:
0.38
시가총액:
$61.13M
수익:
$442.00K
순이익/손실:
$-30.46M
주가수익비율:
-1.1637
EPS:
-4.46
순현금흐름:
$-27.47M
1주 성능:
+9.73%
1개월 성능:
-16.96%
6개월 성능:
+42.19%
1년 성능:
+14.82%
1일 변동 폭
$4.93
$5.25
1주일 범위
$4.74
$5.43
52주 변동 폭
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
명칭
Clene Inc
전화
801-676-9695
주소
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
CLNN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
5.19 | 59.72M | 442.00K | -30.46M | -27.47M | -4.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-10-04 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-07-18 | 개시 | H.C. Wainwright | Buy |
| 2022-05-02 | 개시 | Canaccord Genuity | Buy |
| 2021-09-28 | 개시 | Oppenheimer | Outperform |
Clene Inc 주식(CLNN)의 최신 뉴스
Best Nanotechnology Stocks To Add to Your WatchlistJanuary 27th - MarketBeat
Top Nanotechnology Stocks To Follow NowJanuary 26th - MarketBeat
Breakout Watch: Will Clene Inc benefit from AI trendsPortfolio Gains Summary & Capital Protection Trade Alerts - baoquankhu1.vn
Promising Nanotechnology Stocks To Follow TodayJanuary 25th - MarketBeat
Aug Breakouts: Should I buy Tile Shop Holdings Inc stock now2025 Trading Volume Trends & AI Based Trade Execution Alerts - baoquankhu1.vn
Nanotechnology Stocks To Watch TodayJanuary 24th - MarketBeat
Chidozie Ugwumba Sells 12,665 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 5,556 Shares of Stock - MarketBeat
Technical Analysis: How do insiders feel about Clene Inc Equity WarrantQuarterly Earnings Summary & Fast Entry Momentum Alerts - baoquankhu1.vn
Promising Nanotechnology Stocks To Watch NowJanuary 23rd - MarketBeat
Clene Inc. (NASDAQ:CLNN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Clene Conference: FDA Grants Type C Meeting as CLNN Eyes ALS CNM-Au8 Accelerated Approval in Q2 - Yahoo Finance
Nanotechnology Stocks To Watch NowJanuary 22nd - MarketBeat
Chidozie Ugwumba Sells 12,119 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 7,923 Shares - MarketBeat
Chidozie Ugwumba Sells 12,432 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Clene Inc. ten percent owner sells $161k in shares By Investing.com - Investing.com Australia
Clene Inc. ten percent owner sells $161k in shares - Investing.com
CLNN: FDA to review ALS therapy data this quarter; NDA filing and commercialization targeted for 2025 - TradingView
Should I hold or sell Regency Centers Corporation nowQuarterly Trade Report & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Top Nanotechnology Stocks To Follow TodayJanuary 8th - MarketBeat
Insider Buy: What is the PEG ratio of Clene Inc2025 Trading Recap & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream - Investing News Network
Promising Nanotechnology Stocks To Add to Your WatchlistJanuary 18th - MarketBeat
Top Nanotechnology Stocks To Add to Your WatchlistJanuary 4th - MarketBeat
Nanotechnology Stocks Worth WatchingJanuary 17th - MarketBeat
Growth Value: Will PG E Corporation Preferred Security benefit from rising consumer demandSell Signal & Intraday High Probability Alerts - baoquankhu1.vn
Clene Inc. ten percent owner sells $292,184 in shares By Investing.com - Investing.com Australia
Trading Action: Is Clene Inc exposed to currency risksEarnings Growth Report & High Conviction Investment Ideas - baoquankhu1.vn
Shorts Report: Will CLNN stock recover after earningsMarket Movement Recap & Weekly Return Optimization Plans - baoquankhu1.vn
Aug Technicals: Is Clene Inc Equity Warrant stock a smart retirement pickWeekly Risk Summary & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Best Nanotechnology Stocks Worth WatchingJanuary 16th - MarketBeat
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 19,621 Shares of Stock - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 26,105 Shares - MarketBeat
Clene Inc. ten percent owner sells $292,184 in shares - Investing.com
Clene to Present at the Emerging Growth Conference - Investing News Network
Best Nanotechnology Stocks To Follow TodayJanuary 15th - MarketBeat
Clene, FDA to discuss survival data and approval path for CNM-Au8 - ALS News Today
Winners Losers: Is Clene Inc a top pick in the sectorGap Up & Long-Term Growth Stock Strategies - baoquankhu1.vn
Risks Report: Is Clene Inc Equity Warrant stock positioned well for digital economyWeekly Profit Summary & AI Forecasted Entry/Exit Points - Bộ Nội Vụ
Clene (NASDAQ:CLNN) Director David Matlin Purchases 33,333 Shares of Stock - MarketBeat
Insider Buying: David Matlin Acquires Shares of Clene Inc (CLNN) - GuruFocus
Clene Announces Multi-Tranche Financing to Extend Cash Runway - TipRanks
Clene Signs Multiple Financing Agreements - TradingView
Forecast Cut: Is Clene Inc. stock dividend yield sustainableQuarterly Profit Report & High Accuracy Investment Entry Signals - Bộ Nội Vụ
Promising Nanotechnology Stocks To Follow NowJanuary 13th - MarketBeat
FDA grants Clene in-person meeting to discuss ALS drug biomarker data - Investing.com Nigeria
Published on: 2026-01-13 07:04:12 - Улправда
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells $19,457.55 in Stock - MarketBeat
Clene Inc. ten percent owner sells $256k in shares - Investing.com
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 32,705 Shares of Stock - MarketBeat
Clene Inc (CLNN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.09%
0.48%
자본화:
|
볼륨(24시간):